Post-transplant glucose status in 61 pediatric renal transplant recipients: Preliminary results of five Turkish pediatric nephrology centers

Pediatric Transplantation

Volumn 14, Issue 2, 2010, Pages 203-211

  Buyan, Necla ^a   Bilge, Ilmay ^b   Turkmen, Mehmet A ^c   Bayrakci, Umut ^d   Emre, Sevinc ^b   Fidan, Kibriya ^a   Baskin, Esra ^e   Gok, Faysal ^f   Bas, Firdevs ^b   Bideci, Aysun ^a  

^a GAZI UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c DOKUZ EYLUL UNIVERSITY   (Turkey)

^d HACETTEPE UNIVERSITY   (Turkey)

^e BASKENT UNIVERSITY   (Turkey)

^f GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Calcineurin inhibitors; Children; Complications; Immunosuppression; Kidney transplantation; Long term results

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS; TRIACYLGLYCEROL;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; ARTICLE; BODY MASS; CHILD; CHOLESTEROL BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN TREATMENT; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PEDIATRIC HOSPITAL; POSTOPERATIVE COMPLICATION; POSTTRANSPLANT DIABETES MELLITUS; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; TURKEY (REPUBLIC);

ADOLESCENT; BLOOD GLUCOSE; CHILD; DIABETES MELLITUS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INSULIN RESISTANCE; KIDNEY TRANSPLANTATION; MALE; PROSPECTIVE STUDIES;

EID: 76449113938     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2009.01192.x     Document Type: Article

References (49)

1. Montori VM, Basu A, Erwin PJ, Velosa JA, Gabriel SE, Kudva YC. Post transplantation diabetes. Diabetes Care 2002 : 25 : 583 592.
2. Ravindran V, Baboolal K, Moore R. Posttransplant diabetes mellitus after renal transplantation: The emerging clinical challange. Yonsei Med J 2004 : 45 : 1059 1064.
3. Pham PT, Pham PC, Lipshutz GS, Wilkinson AH. New onset diabetes mellitus after solid organ transplantation. Endocrinol Metab Clin North Am 2007 : 36 : 873 890.
4. Bloom RD, Crutchlow MF. New-onset diabetes mellitus in the kidney recipient: Diagnosis and management strategies. Clin J Am Soc Nephrol 2008 : 3 (Suppl. 2 S38 S48.
5. Saleem TFM, Cunnigham KE, Hollenbeak CS, Alfrey EJ, Gabbay RA. Development of diabetes mellitus post-renal transplantation is associated with poor short-term clinical outcomes. Transplant Proc 2003 : 35 : 2916 2918.
6. Miles AM, Sumrani N, Horowitz R, et al. Diabetes mellitus after renal transplantation: As deleterious as non-transplant-associated diabetes? Transplantation 1998 : 65 : 380 384.
7. Hjelmesæth J, Asberg A, Müller F, Hartmann A, Jenssen T. New-onset posttransplantation diabetes mellitus: Insulin resistance or insulinopenia? Impact of immunosuppressive drugs, cytomegalovirus and hepatitis C virus infection. Curr Diabetes Rev 2005 : 1 : 1 10.
8. Ekstrand AV, Eriksson JG, Gronhagen-Riska C, Ahonen PJ, Groop LC. Insulin resistance and insulin deficiency in the pathogenesis of posttransplantation diabetes in man. Transplantation 1992 : 53 : 563 569.
9. Weir MR, Fink JC. Risk for posttransplant diabetes mellitus with current immunosuppressive medications. Am J Kidney Dis 1999 : 34 : 1 13.
10. Hricik DE, Almawi WY, Strom TB. Trends in the use of glucocorticoids in renal transplantation. Transplantation 1994 : 57 : 979 989.
11. Plosker GL, Foster RH. Tacrolimus: A further update of its pharmacology and therapeutic use in the management of organ transplantation. Drugs 2000 : 59 : 323 389.
12. Pirsch JD, Miller J, Deierhoi MH, Vincenti F, Filo RS. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK 506 Kidney Transplant Study Group. Transplantation 1997 : 63 : 977 983.
13. Trompeter R, Filler G, Webb NJ, et al. Randomized trial of tacrolimus versus cyclosporin microemulsion in renal tranplantation. Pediatr Nephrol 2002 : 17 : 141 149.
14. Burroughs TE, Lentine KL, Takemoto SK, et al. Influence of early posttransplantation prednisone and calcineurin inhibitor dosages on the incidence of new-onset diabetes. Clin J Am Soc Nephrol 2007 : 2 : 517 523.
15. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003 : 3 : 178 185.
16. Greenspan LC, Gitelman SE, Leung MA, Glidden DV, Mathias RS. Increased incidence in post-transplant diabetes mellitus in children: A case-control analysis. Pediatr Nephrol 2002 : 17 : 1 5.
17. Al-Uzri A, Stablein DM, Cohn R. Posttransplant diabetes mellitus in pediatric renal transplant recipients: a report of the North American Pediatric renal Transplant Cooperative Study (NAPRTCS). Transplantation 2001 : 72 : 1020 1024.
18. Paolillo JA, Boyle GJ, Law YM, et al. Posttransplant diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression. Transplantation 2001 : 71 : 252 256.
19. Shishido S, Sato H, Asanuma H, et al. Unexpectedly high prevalence of pretransplant abnormal glucose tolerance in pediatric kidney transplant recipients. Pediatr Transplant 2006 : 10 : 67 73.
20. Rosenbloom Al, Joe JR, Young RS, Winter WE. Emerging epidemic of type 2 diabetes in youth. Diabetes Care 1999 : 22 : 345 354.
21. Pinhas-Hamiel O, Dolan LM, Daniels SR, Standiford D, Khoury PR, Zeitler P. Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. J Pediatr 1996 : 128 : 608 615.
22. Vesco L, Busson M, Bedrossian J, Bitker MO, Hiesse C, Lang P. Diabetes mellitus after renal transplantation: Characteristics, outcome and risk factors. Transplantation 1996 : 61 : 1475 1478.
23. Knol GA. Tacrolimus versus cyclosporin for immunosuppression in renal transplantation: Meta-analysis of randomized trials. BMJ 1999 : 24 : 318.
24. Kuczmarski RJ, Flegal KM. Criteria for definition of overweight in transition: Background and recommendations for the United States. Am J Clin Nutr 2000 : 72 : 1074 1081.
25. Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000 : 85 : 2402 2410.
26. American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003 : 26 (Suppl. 1 S5 S20.
27. Davidson J, Wilkinson A. International expert panel on new-onset diabetes after transplantation. New-onset diabetes after transplantation 2003 International Consensus Guidelines: An endocrinologist's view. Diabetes Care 2004 : 27 : 805 812.
28. Cosio FG, Pesavento TE, Kim S, Osei K, Henry M, Ferguson RM. Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney Int 2002 : 62 : 1440 1446.
29. Lindholm A, Albrechtsen D, Frodin L, Tufveson G, Persson NH, Lundgren G. Ischemic heart disease - Major cause of death and graft loss after renal transplantation in Scandinavia. Transplantation 1995 : 60 : 451 457.
30. Revanur VK, Jardine AG, Kingsmore DB, Jaques BC, Hamilton DH, Jindal RM. Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation. Clin Transplant 2001 : 15 : 89 94.
31. Armstrong KA, Prins JB, Beller EM, et al. Should an oral glucose tolerance test be performed routinely in all renal transplant recipients? Clin J Am Soc Nephrol 2006 : 1 : 100 108.
32. Gourishankar S, Jhangri GS, Tonelli M, Wales LH, Cockfield SM. Development of diabetes mellitus following kidney transplantation: A Canadian experience. Am J Transplant 2004 : 4 : 1876 1882.
33. First MR. Improving long-term renal transplant outcomes with tacrolimus: Speculation vs evidence. Nephrol Dial Transplant 2004 : 19 (Suppl. 6 vi17 vi22.
34. Kamar N, Mariat C, Delahousse M, et al. Diabetes mellitus after kidney transplantation: A French multicentre observational study. Nephrol Dial Transplant 2007 : 22 : 1986 1993.
35. Joss N, Staatz CE, Thomson AH, Jardine AG. Predictors of new onset diabetes after renal transplantation. Clin Transplant 2007 : 21 : 136 143.
36. US Renal Data System. USRDS 2003 Annual Data Report. Atlas of End-Stage Renal Disease in the United States. Bethesda, MD : National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2003.
37. Hanevold CD, Ho PL, Talley L, Mitsnefes MM. Obesity and renal transplant outcome: A report of the North American Pediatric Renal Transplant Cooperative Study. Pediatrics 2005 : 115 : 352 356.
38. Mitsnefes MM, Khoury P, McEnery PT. Body mass index and allograft function in pediatric renal transplantation. Pediatr Nephrol 2002 : 17 : 535 539.
39. Meier-Kriesche HU, Arndorfer JA, Kaplan B. The impact of body mass index on renal transplant outcomes: A significant independent risk factor for graft failure and patient death. Transplantation 2002 : 73 : 70 74.
40. Castillo DD, Cruzado JM, Diaz JM, et al. The effects of hyperlipidemia on graft and patient outcome in renal transplantation. Nephrol Dial Transplant 2004 : 19 (Suppl. 3 iii67 iii71.
41. Henkel E, Temelkova-Kurktschiev T, Koehler C, Pietzsch J, Leonhardt W, Hanefeld M. Impaired glucose tolerance is not associated with lipid intolerance. Diabetes Nutr Metab 2002 : 15 : 84 90.
42. Mayer AD, Dmitrewski J, Squifflet JP, et al. Multicenter randomized trial comparising tacrolimus (FK506) and cyclosporine in the preventation of renal allograft rejection: A report of the European Tacrolimus Multicenter Renal Study Group. Transplantation 1997 : 64 : 436 443.
43. Vincenti F, Friman S, Scheuermann E, et al. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant 2007 : 7 : 1506 1514.
44. Shapiro R, Jordan ML, Scantlebury VP, et al. A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients. Transplantation 1999 : 3 : 411 415. (Pubitemid 29094012)
45. Moore R, Boucher A, Carter J, et al. Diabetes mellitus in transplantation: 2002 consensus guidelines. Transplant Proc 2003 : 35 : 1265 1270.
46. Uwaifo GI, Fallon EM, Chin J, Elberg J, Parikh SJ, Yanovski J. Indices of insulin action, disposal, and secretion derived from fasting samples and clamps in normal glucose-tolerant black and white children. Diabetes Care 2002 : 25 : 2081 2087.
47. Song Y, Manson JE, Tinker L, et al. Insulin sensitivity and insulin secretion determined by homeostasis model assessment (HOMA) and risk of diabetes in a multiethnic cohort of women: The Women's Health Initiative Observational Study. Diabetes Care 2007 : 30 : 1747 1752. (Pubitemid 47036347)
48. Haffner SM, Kennedy E, Gonzalez C, Stern MP, Miettinen H. A prospective analysis of the HOMA model: The Mexico City Diabetes Study. Diabetes Care 1996 : 19 : 1138 1141.
49. Osei K, Rhinesmith S, Gaillard T, Schuster D. Impaired insulin sensitivity, insulin secretion, and glucose effectiveness predict future development of impaired glucose tolerance and type 2 diabetes in pre-diabetic African Americans: Implications for primary diabetes prevention. Diabetes Care 2004 : 27 : 1439 1446. (Pubitemid 38679995)